Filing Details
- Accession Number:
- 0001209191-21-028637
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-27 17:58:52
- Reporting Period:
- 2021-04-23
- Accepted Time:
- 2021-04-27 17:58:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1770787 | 10X Genomics Inc. | TXG | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1651325 | Sridhar Kosaraju | C/O 10X Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton CA 94588 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2021-04-23 | 100 | $190.05 | 16,400 | No | 4 | S | Indirect | See Footnote |
Class A Common Stock | Disposition | 2021-04-23 | 300 | $191.71 | 16,100 | No | 4 | S | Indirect | See Footnote |
Class A Common Stock | Disposition | 2021-04-23 | 400 | $193.11 | 15,700 | No | 4 | S | Indirect | See Footnote |
Class A Common Stock | Disposition | 2021-04-23 | 600 | $193.98 | 15,100 | No | 4 | S | Indirect | See Footnote |
Class A Common Stock | Disposition | 2021-04-23 | 100 | $194.74 | 15,000 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust.
- These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust").
- This transaction was executed in multiple trades at prices ranging from $191.50 to $192.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $192.66 to $193.53. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $193.72 to $194.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.